Supreme Court Allows Mifepristone Mail Order Pending Appeal

The U.S. Supreme Court has permitted the mail-order dispensing of the abortion drug mifepristone while an appeal challenging this distribution method is ongoing. The ruling, announced on Thursday, followed a demonstration at the Supreme Court in Washington, D.C., on March 26, 2024. The Court declined to specify the vote count supporting the continuation of the stay or provide a majority explanation. Notably, conservative justices Clarence Thomas and Samuel Alito issued written dissents regarding the decision.

The U.S. Supreme Court has ruled that mail-order access to the abortion drug mifepristone will remain permissible while an appeal challenging the drug's distribution method is pending. This decision was announced on Thursday, following a demonstration at the Supreme Court in Washington, D.C., on March 26, 2024.

Key Details of the Ruling

The Court's ruling specifically addresses the ability to receive mifepristone via mail order while the legal challenge concerning this distribution method is under appeal.

The Supreme Court did not disclose the vote count among the nine justices regarding the continuation of the stay on the lower court's order.
Furthermore, the majority of the justices did not provide a written explanation for their decision.

Judicial Dissent

Two conservative justices, Clarence Thomas and Samuel Alito, issued written dissents following the Court's decision.